MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2026 International Congress

    Impulse-compulsive disorders and non-motor symptom profiles in Parkinson’s disease: findings from a Tunisian cohort

    E. Cherif, A. Rekik, A. Mili, K. Jemai, A. Hsini, H. Slimen, S. Naija, A. Hassine, S. Ben Amor (Sousse, Tunisia)

    Objective: To examine the relationship between impulse-compulsive disorders (ICDs) and non-motor symptom profiles in patients with Parkinson’s disease (PD). Background: ICDs are recognized non-motor complications…
  • 2026 International Congress

    Cognition and Dementia in a Kenyan Parkinson’s Disease Cohort: A Sub-study of the TraPCAf Consortium

    J. Nambafu, D. Sokhi, J. Hooker, M. Pambo, M. Parsemei, B. Mghendi (Nairobi, Kenya)

    Objective: To describe Cognitive Impairment in the Kenyan PD TraPCAf cohort. Background: The epidemiology and natural history, including cognitive impairment (CI) of Parkinson's disease (PD)…
  • 2026 International Congress

    Should we really forget DBS in Parkinson’s Patients with Dementia?

    D. Natarajan (Tirupati, India)

    Objective: To determine whether DBS is really an absolute contraindication in patients with Parkinson’s dementia. Background: It is well established in the literature that Parkinson’s…
  • 2026 International Congress

    Parkinson disease psychosis: A systematic review and meta-analysis

    J. Hinkle, J. Blackband, B. Garner, K. Perepezko, C. Morrow, A. Chowdhury, K. Mills, A. Mahajan, A. Martinez-Nunez, G. Pontone (Baltimore, USA)

    Objective: To determine the prevalence of Parkinson disease psychosis (PDP) as a function of several putative risk factors: PD duration, age, cognitive impairment, dopaminergic or…
  • 2026 International Congress

    A Phase 3, Multinational, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial (IB1001-304) Evaluating Levacetylleucine in CACNA1A Disorders

    B. Zanrucha, T. Bremova-Ertl, M. Patterson, M. Strupp, J. Kerthi, J. Raymond, T. Fields, I. Billington, K. Martakis (Austin, USA)

    Objective: To assess the efficacy, safety, and tolerability of levacetylleucine in people with CACNA1A disorders. Background: CACNA1A disorders refer to a range of rare, progressive,…
  • 2026 International Congress

    Cognitive Impairment and Agent Orange Exposure in Veterans with Essential Tremor.

    R. Menodiado, D. Padilla, F. Jamal (Houston, USA)

    Objective: The objective of this study is to determine differences in cognitive profiles among Veterans with Essential Tremor (ET) who were exposed to agent orange…
  • 2026 International Congress

    Investigation of Sex-based Differences in the Utility of IgG Index as a Potential Predictor of Cognitive Impairment in Parkinson’s Disease

    R. Edillor, J. Ruiz-Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: Determine if there are sex-based differences in associations of baseline (BL) immunoglobulin G (IgG) index with development of cognitive impairment (CI) among cognitively normal…
  • 2026 International Congress

    Executive Dysfunction as a Determinant of Functional Impairment in Parkinson’s Disease

    N. Adhitama, R. Ibonita, R. Puspa, M. Wedariani, A. Devicaesaria, S. Lumempouw (East Jakarta, Indonesia)

    Objective: To evaluate executive function across cognitive stages of Parkinson’s disease and examine its association with functional impairment. Background: Executive dysfunction is one of the…
  • 2026 International Congress

    Biofluid Markers in Parkinson’s Patients and Correlation with Cognitive Profile

    T. Yamasaki, R. Vivanco, J. Johnson, S. Ali, F. Schmitt, A. Glueck, A. Jacob, S. Hulou, M. Khashimov, K. Tackett, C. Logan, J. Stegemann, E. Song, E. Ostrakhovitch (Lexington, USA)

    Objective: The purpose of this study was to determine potential biofluid biomarkers for cognitive impairment in a cohort of Parkinson's disease (PD) patients. Here we…
  • 2026 International Congress

    Cognitive profiles in idiopathic normal pressure hydrocephalus: clinical patterns and the impact of coexisting neurodegeneration

    C. Espinoza-Vinces, I. Avilés-Olmos, G. Montoya-Murillo, J. Núñez-Córdoba, M. Luquin (Pamplona, Spain)

    Objective: To characterise cognitive severity and domain-specific profiles in patients with idiopathic normal pressure hydrocephalus (iNPH) and to examine the impact of coexisting neurodegeneration. Background:…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley